These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7508844)

  • 1. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China.
    Gu F
    Chin Med J (Engl); 2000 Apr; 113(4):299-302. PubMed ID: 11775222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China.
    Gu FL; Xia TL; Kong XT
    Urology; 1994 Nov; 44(5):688-91. PubMed ID: 7526525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology and natural course of benign prostatic hyperplasia].
    Blom JH; Schröder FH
    Urologe A; 1992 May; 31(3):129-34. PubMed ID: 1377429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
    Pacelli A; Bostwick DG
    Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis.
    Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF
    Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the prevalence of benign prostatic hyperplasia in China.
    Gu F
    Chin Med J (Engl); 1997 Mar; 110(3):163-6. PubMed ID: 9594331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of benign prostatic hyperplasia drugs on incidence and pathology grading of prostate cancer].
    Zhu J; Gao JP; Xu AX; Lü XY; Cui L; Hong BF; Zhang X
    Zhonghua Wai Ke Za Zhi; 2010 May; 48(10):761-3. PubMed ID: 20646494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate.
    Shakya G; Malla S; Shakya KN
    Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The frequency of surgery of benign prostatic hypertrophy].
    Janin P; Haillot O; Boutin JM; Lesourd B; Hubert B; Lanson Y
    Prog Urol; 1995 Sep; 5(4):515-21. PubMed ID: 7581501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
    Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
    Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?
    Hall MC; Roehrborn CG; McConnell JD
    Semin Urol Oncol; 1996 Aug; 14(3):122-33. PubMed ID: 8865473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.